bebtelovimab

Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Endpoints
Wed, 11/30/22 - 08:04 pm
Eli Lilly
FDA
COVID-19
Omicron
bebtelovimab
monoclonal antibodies
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Mon, 09/26/22 - 11:29 pm
Eli Lilly
COVID-19
bebtelovimab
federal contracts
HHS
Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful
Fierce Pharma
Fri, 02/11/22 - 11:48 am
Eli Lilly
monoclonal antibodies
COVID-19
bebtelovimab